Tahara, Makoto http://orcid.org/0000-0001-9035-3106
Okano, Susumu
Enokida, Tomohiro
Ueda, Yuri
Fujisawa, Takao
Shinozaki, Takeshi
Tomioka, Toshifumi
Okano, Wataru
Biel, Merrill A.
Ishida, Kosuke
Hayashi, Ryuichi
Funding for this research was provided by:
Rakuten Medical Inc
Article History
Received: 24 February 2021
Accepted: 3 June 2021
First Online: 24 June 2021
Declarations
:
: Makoto Tahara: research expenses (AstraZeneca, MSD, Bayer, Pfizer, Ono); lecturer fee (Eisai, Merck Serono, BMS, Ono). Susumu Okano: Honoraria (Merck Serono, MSD, Eisai, Ono, Bristol-Myers). Tomohiro Enokida: no conflicts to disclose. Yuri Ueda: lecturer fee (Merck Serono, BMS). Takao Fujisawa: no conflicts to disclose. Takeshi Shinozaki: lecturer fee (Rakuten Medical Inc). Toshifumi Tomioka: no conflicts to disclose. Wataru Okano: no conflicts to disclose. Merrill A. Biel: prior employment (Rakuten Medical Inc.); leadership (Rakuten Medical Inc.); stock and other ownership interests (Rakuten Medical Inc.); travel, accommodation, expenses (Rakuten Medical Inc.). Kosuke Ishida: employment (Rakuten Medical Inc; Boehringer Ingelheim); stock and other ownership interests (Rakuten Medical Inc.). Ryuichi Hayashi: lecturer fee (Rakuten Medical Inc).